XML 57 R23.htm IDEA: XBRL DOCUMENT
v2.4.0.8

17. RESEARCH AND DEVELOPMENT EXPENSES | 9 Months Ended
--- | ---
Sep. 30, 2014
Notes to Financial Statements |
17. RESEARCH AND DEVELOPMENT EXPENSES | The total research and development expenses recognized in the income statements during the three-month and nine-month periods ended September 30, 2014 were $30,985 and $94,322, respectively, of which the consumption of bromine produced by the Company amounted to $8,547 and $26,054, respectively. The total research and development expenses recognized in the income statements during the three-month and nine-month periods ended September 30, 2013 were $33,198 and $105,380, respectively, of which the consumption of bromine produced by the Company amounted to $8,803 and $27,385, respectively.

X
- Details
Name: | gure_NotesToFinancialStatementsAbstract
Namespace Prefix: | gure_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition No authoritative reference available. + References No definition available. + Details
Name: | gure_ResearchAndDevelopmentExpensesDisclosureTextblock
Namespace Prefix: | gure_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration